Goldenwell Biotech, Inc. (GWLL)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2340.00 | 47.8 Thousand | 15.96 Thousand | - | - |
| Cost of Revenue | 1232.00 | 22.61 Thousand | 7579.00 | - | - |
| Gross Profit | 1108.00 | 25.18 Thousand | 8388.00 | - | - |
| Operating Expenses | 118 Thousand | 1.01 Million | 126.65 Thousand | 6368.00 | 6933.00 |
| Selling, General and Administrative Expenses | 118 Thousand | 1.01 Million | 126.65 Thousand | 6368.00 | 7803.00 |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | - | 8.00 | 1286.00 | 44.00 | - |
| Cost and Expenses | 119.23 Thousand | 1.03 Million | 134.23 Thousand | 6368.00 | 6933.00 |
| Operating Income | -116.89 Thousand | -985.1 Thousand | -118.26 Thousand | -6368.00 | -7803.00 |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | - | -985.1 Thousand | -118.26 Thousand | -6368.00 | 870.00 |
| Earnings before Tax | -116.89 Thousand | -985.09 Thousand | -116.98 Thousand | -6324.00 | -6933.00 |
| Net Income | -116.89 Thousand | -985.09 Thousand | -116.98 Thousand | -6324.00 | -6933.00 |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 96.44 Million | 96.43 Million | 91.32 Million | 96 Million | 76.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.43 Million | 96.43 Million | 91.32 Million | 96 Million | 76.19 Million |
| Gross Margin | 0.47 | 0.53 | 0.53 | - | - |
| EBIT Margin | -49.96 | -20.61 | -7.41 | - | - |
| Profit Margin | -49.96 | -20.61 | -7.33 | - | - |
| EBITDA | -116.89 Thousand | - | - | - | - |
| Earnings Before Tax Margin | -49.96 | -20.61 | -7.41 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 139.00 | 158.00 | 260.00 | 2340.00 | 382.00 | 276.00 |
| Cost of Revenue | 69.00 | 79.00 | 187.00 | 1232.00 | 196.00 | 138.00 |
| Gross Profit | 70.00 | 79.00 | 73.00 | 1108.00 | 186.00 | 138.00 |
| Operating Expenses | 49.99 Thousand | 31.05 Thousand | 20.87 Thousand | 118 Thousand | 35.59 Thousand | 27.22 Thousand |
| Selling, General and Administrative Expenses | 49.99 Thousand | 31.05 Thousand | 20.87 Thousand | - | 35.59 Thousand | 27.22 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 50.05 Thousand | 31.13 Thousand | 21.05 Thousand | 119.23 Thousand | 35.78 Thousand | 27.36 Thousand |
| Operating Income | -49.92 Thousand | -30.97 Thousand | -20.79 Thousand | -116.89 Thousand | -35.4 Thousand | -27.08 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -49.92 Thousand | -30.97 Thousand | -20.79 Thousand | -116.89 Thousand | -35.4 Thousand | -27.08 Thousand |
| Earnings before Tax | -49.92 Thousand | -30.97 Thousand | -20.79 Thousand | -116.89 Thousand | -35.4 Thousand | -27.08 Thousand |
| Net Income | -49.92 Thousand | -30.97 Thousand | -20.79 Thousand | -116.89 Thousand | -35.4 Thousand | -27.08 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 96.43 Million | 96.43 Million | 96.43 Million | 96.44 Million | 96.43 Million | 96.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.43 Million | 96.43 Million | 96.43 Million | 96.43 Million | 96.43 Million | 96.43 Million |
| Gross Margin | 0.50 | 0.50 | 0.28 | 0.47 | 0.49 | 0.50 |
| EBIT Margin | -359.14 | -196.06 | -80.00 | - | -92.69 | -98.13 |
| Profit Margin | -359.14 | -196.06 | -80.00 | -49.96 | -92.69 | -98.13 |
| EBITDA | -49.92 Thousand | -30.97 Thousand | -20.79 Thousand | - | -35.4 Thousand | -27.08 Thousand |
| Earnings Before Tax Margin | -359.14 | -196.06 | -80.00 | -49.96 | -92.69 | -98.13 |
AFSIM
RAMP
0050
AH
SMLISUZU
VKSC